India's Pharmaceutical Exports

Country Profile

Bahamas

Bahamas is a developing market for Indian pharmaceuticals — $1.59M in FY 2025–26. Medicines accounts for 96% of shipments, with vaccines contributing $56K. The compound annual growth rate since FY2015 stands at 3.7%.

🇧🇸 $1.59M · 1.5× growth since FY2015 · 3.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$1.59M
Exports FY2025–26 DGCIS
1.5×
Growth FY2015→2026
3.7%
CAGR FY2015→2026
96%
Medicines Share
3
Product Categories Supplied
Bahamas is a developing market for Indian pharmaceuticals — $1.59M in FY 2025–26. Medicines accounts for 96% of shipments, with vaccines contributing $56K. The compound annual growth rate since FY2015 stands at 3.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $1.53M (96.0%) Vaccines $56K (3.5%) Surgical & Hospital Supplies $8K (0.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Bahamas in the RBI overseas direct investment dataset (2011–2026).